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Abstract 32 
Bovine genital campylobacteriosis (BGC), caused by 33 
Campylobacter fetus subsp. venerealis, is associated with 34 
production losses in cattle worldwide. This study aimed to 35 
develop a reliable BGC guinea pig model to facilitate future 36 
studies of pathogenicity, abortion mechanisms and vaccine 37 
efficacy. Seven groups of 5 pregnant guinea pigs (1 control per 38 
group) were inoculated with one of three strains via intra-39 
peritoneal (IP) or intra-vaginal routes. Samples were examined 40 
using culture, PCR and histology. Abortions ranged from 0% to 41 
100% and re-isolation of causative bacteria from sampled sites 42 
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varied with strain, dose of bacteria and time to abortion. 43 
Histology indicated metritis and placentitis, suggesting that 44 
the bacteria induce inflammation, placental detachment and 45 
subsequent abortion. Variation of virulence between strains 46 
was observed and determined by culture and abortion rates. 47 
IP administration of C. fetus subsp. venerealis to pregnant 48 
guinea pigs is a promising small animal model for the 49 
investigation of BGC abortion. 50 
Keywords 51 
C. fetus subspecies venerealis, campylobacteriosis, placentitis, 52 
bovine, guinea pig53 
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Introduction 54 
Bovine genital campylobacteriosis (BGC) caused by C. fetus 55 
subsp. venerealis is a reproductive disease affecting many 56 
cattle herds (World Organisation for Animal Health, 2012). It 57 
has been associated with production losses in the Australian 58 
meat and dairy industry of up to 60% due to abortion and 59 
infertility in infected heifers (Clark et al., 1975). The bacterium 60 
is often asymptomatically carried by bulls, therefore diagnosis, 61 
treatment and control measures may be limited. It is 62 
venereally transmitted to heifers during mating. Heifers may 63 
either remain asymptomatic or experience late term abortions 64 
(Hum, 2009). This can lead to a continuous cycle of infection 65 
and infertility which may affect herd pregnancy rates (Clark, 66 
1971). 67 
Preventative and control measures for BGC exist in the form of 68 
controlled mating, antibiotic administration and vaccines. 69 
South American studies have found that vaccines are not 70 
always efficacious, with variation in protection offered by 71 
different vaccines against different strains (Cobo et al., 2003). 72 
This may be due to variation in strain virulence which is 73 
currently largely unknown. To define the level of pathogenicity 74 
and virulence variation present in C. fetus subsp. venerealis 75 
strains and to determine strain pathogenicity, a model for 76 
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analysing and defining infection parameters is necessary. 77 
While in vitro models are much more ethical and financially 78 
viable, a greater understanding of the bacterial genes 79 
associated with virulence is needed and only single gene 80 
mutants can be examined in a single experiment (Kienesberger 81 
et al., 2007).  In addition, in vitro models can only address one 82 
aspect of virulence i.e. epithelial cell invasion. 83 
Guinea pig models have previously been used to assess 84 
variation in pathogenicity of Campylobacter species and 85 
strains including those of veterinary significance (Burrough, 86 
2011; Burrough et al., 2009; Coid et al., 1987; SultanDosa et 87 
al., 1983). However, a model for determining C. fetus subsp. 88 
venerealis virulence has not been evaluated since its initial 89 
development 60 years ago (Ristic and Morse, 1953), while 90 
recent scientific advances (such as PCR) could improve model 91 
assessment. The model has not been used for the study of 92 
Australian strains, which may have different pathogenic 93 
characteristics to those in North America where the original 94 
study was undertaken (Ristic and Morse, 1953).  An Australian 95 
based polymerase chain reaction assay could not differentiate 96 
UK C. fetus subspecies correctly hypothesising that a unique 97 
clone was present in the UK (Hum et al., 1997; Willoughby et 98 
al., 2005). This may be due to different bacterial environments 99 
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as well as antibiotic treatments which can impact bacterial 100 
genetic variation. The significance of a guinea pig infection 101 
model was shown in further studies using a variety of human 102 
Campylobacter species (but not C. fetus) with culture for 103 
diagnosis (Coid et al., 1987; Taylor and Bryner, 1984). Recent 104 
studies into C. jejuni infection models have included the 105 
examination of histological findings to substantiate the 106 
bacterial involvement in abortion (Burrough et al., 2011; 107 
Burrough et al., 2009). 108 
This study aimed to develop an animal model to assess 109 
variation in strain pathogenicity and subsequent abortions 110 
caused by different C. fetus subsp. venerealis strains. The 111 
model was established with accurate, defined parameters for 112 
the identification of dose, route and strains of C. fetus subsp. 113 
venerealis for further studies. The model was evaluated at a 114 
range of low, medium and high doses and using one of two 115 
different infection routes (intra-peritoneal and intra-vaginal). 116 
Subsequently culture, PCR and histology were compared to 117 
determine the presence of bacteria and the pathological 118 
changes associated with infection.  119 
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Materials and Methods 120 
Ethical Statement 121 
This study was approved by the University of Queensland 122 
Animal Ethics Committee (SVS070/10). 123 
Study Design 124 
The study was designed as a controlled experimental trial with 125 
thirty-five female guinea pigs (Cavia porcellus) obtained from 126 
the University of Queensland’s guinea pig breeding facility 127 
(Gatton campus) allocated to seven groups of 5 dams. Guinea 128 
pigs were assigned to groups in the order they became 129 
pregnant. Guinea pigs were housed in floor pens with wood 130 
shavings and had access to vitamin C supplemented water (1 131 
g/l) and Barastoc guinea pig pellets (Ridley AgriProducts, 132 
Melbourne, Australia) ad libitum as well as fresh vegetables 133 
daily.  134 
At the commencement of the study, 20 of the guinea pigs 135 
were tested for the presence of C. fetus subsp. venerealis or 136 
Campylobacter-like organisms (curved rod organisms growing 137 
under microaerobic conditions), by swabbing the vaginal area 138 
with a sterile cotton swab and placing it in PBS for transport to 139 
the lab where it was streaked out onto a sheep-blood agar 140 
(SBA) plate (Oxoid Australia, ThermoFisher Scientific, MA, USA) 141 
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and incubated in a microaerobic workstation (Don Whitely 142 
Scientific, Shipley, UK) at 37°C for 72 h.  143 
Abortion (defined as the expulsion of one or more foetuses or 144 
placentas) was the primary outcome. Guinea pigs were 145 
randomly housed in groups of 6-8 by blindly allocating dams to 146 
each pen with one male for mating purposes. They were then 147 
assigned to groups as they became pregnant based on closest 148 
gestational ages. Pregnant guinea pigs were inoculated via 149 
intra-peritoneal (IP) (groups 1-6) or intra-vaginal (IVA) (group 150 
7) route between 5-6 weeks of gestation based on 151 
retrospective calculations of oestrus detection data. Each 152 
group consisted of five animals with an allocation ratio of 4:1 153 
(test: control) per group (control receiving sterile broth) and 154 
were inoculated as shown in Table 1. 155 
Pregnancy Determination 156 
During the mating period, the guinea pigs were oestrus-157 
detected by assessing the opening of the vaginal membrane 158 
(Stockard and Papanicolaou, 1919) once daily. When oestrus 159 
had not been detected for 21 consecutive days, trans-160 
abdominal ultrasound using a MyLab 30 Vet ultrasound 161 
scanner with a 5-10 MHz linear probe (Esaote Pie Medical, 162 
Genoa, Italy) was performed. The presence of embryonic 163 
vesicles with foetuses and heartbeats confirmed pregnancy. 164 
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The first five animals to fall pregnant were used in the first 165 
treatment group, with each subsequent set of five animals 166 
forming the following six treatment groups. 167 
Inoculum Preparation 168 
Three C. fetus subsp. venerealis isolates were utilized in this 169 
study. Strain Q41 (ATCC19438), a control C. fetus subsp. 170 
venerealis  was obtained from New South Wales Department 171 
of Primary Industries, and strains 258 and 540 were obtained 172 
from a bull prepuce abattoir survey with no traceability of bull 173 
infective status (Indjein, 2013). The three strains used were 174 
selected based on three features; 1) the molecular and 175 
biochemical profile matching C. fetus subsp. venerealis 176 
outlined by the World Organisation for Animal Health (World 177 
Organisation for Animal Health, 2012), 2) the viability of the 178 
bacteria 72 h after resuscitation based on bacterial growth and 179 
motility as seen microscopically, and 3) the survival of the 180 
bacteria when inoculated into 5 ml of guinea pig serum and 181 
incubated in a microaerobic workstation for 72 h.  182 
The strains were resuscitated from storage at -80°C by placing 183 
200 µl of one of the stored media, either 85% FBP medium 184 
(Gorman and Adley, 2004) (0.025% ferrous sulphate w/v 185 
(Univar Australia Pty Ltd), 0.025% sodium metabisulphite w/v 186 
(Sigma-Aldrich, MO, USA), 0.025% sodium pyruvate w/v (BDH 187 
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ProLab, VWR International Pty Ltd, Australia) or 15% glycerol 188 
(AnalaR NORMAPUR, VWR International Pty Ltd, Australia), 189 
into 10 ml of vegetable peptone based Campylobacter broth 190 
consisting of 1% vegetable peptone no 1 w/v (Oxoid Australia, 191 
ThermoFisher Scientific, MA, USA), 0.2% sodium succinate w/v 192 
(Merck Australia, Merck KGaA, Germany), 0.5% yeast extract 193 
w/v (Oxoid Australia, ThermoFisher Scientific, MA, USA), 0.5% 194 
sodium chloride w/v (Merck Australia, Merck KGaA, Germany), 195 
0.0001% magnesium sulphate w/v (Univar Australia Pty Ltd, 196 
Australia), 0.5% calcium chloride w/v (Merck Australia, Merck 197 
KGaA, Germany), and 0.15% bacteriological agar w/v (Oxoid 198 
Australia, ThermoFisher Scientific, MA, USA). The broths were 199 
placed into a microaerobic workstation at 37°C and assessed 200 
at 72 h for growth.   201 
Viable strains were profiled using the Hum conventional PCR 202 
(Hum et al., 1997) and characterised biochemically according 203 
to OIE classification (World Organisation for Animal Health, 204 
2012) – catalase, oxidase and growth in 1% glycine medium 205 
(Becton, Dickinson and Company, MD, USA), growth at 42°C, 206 
25°C and aerobically, susceptibility to 30 µg nalidixic acid and 207 
cephalothin (Oxoid Australia, ThermoFisher Scientific, MA, 208 
USA), H2S production in a triple-sugar-iron (TSI) slope (Oxoid 209 
Australia, ThermoFisher Scientific, MA, USA) and in a 0.02% 210 
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cysteine medium (Fluka analytical, Sigma-Aldrich, MO, USA) 211 
using lead acetate paper (Fluka analytical, Sigma-Aldrich, MO, 212 
USA). 213 
The strains identified biochemically as C. fetus subsp. 214 
venerealis, were inoculated into 10 ml of fresh vegetable 215 
peptone based Campylobacter broth (as described above) and 216 
incubated microaerobically at 37°C for 72 h. At 72 h, a serial 217 
dilution of 10-1 to 10-9 CFU/ml was prepared and plated in 218 
duplicate by placing 100 µl of the dilution onto an SBA plate 219 
and spreading it evenly across the surface. The plates were 220 
then incubated in the microaerobic workstation for 72 h. 221 
Subsequently, a comparative cell count using a Helber 222 
bacterial counting chamber (Hawksley, Sussex, UK) was carried 223 
out by creating a 1/10 dilution of the broth in 10% neutral 224 
buffered formalin (NBF) (10% w/v formaldehyde, Merck 225 
Australia, Merck KGaA, Germany) to fix the bacteria. A volume 226 
of 10 µl was placed into the central chamber of the counter, 227 
the cover slide added and viewed under a Nikon Eclipse E400 228 
microscope (Nikon, Tokyo) at 400 x magnification and the 229 
bacterial concentration calculated (Meynell and Meynell, 230 
1970). Concentrations of the inoculum for groups 1-5 and 7 231 
were based on growth at 72 h while group 6 was diluted with 232 
Campylobacter broth to achieve the desired concentration of 233 
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bacterial colonies. Inoculum were streaked out just prior to 234 
inoculation onto two SBA plates, incubated at 37°C either 235 
microaerobically or aerobically to ensure sterility of the broth. 236 
Experimental Procedures 237 
Animal Inoculation 238 
IP inoculation with 1.0 ml of the prepared strain was carried 239 
out using a 21G needle inserted slightly to the left of the 240 
midline of the abdomen after swabbing with iodine. 241 
IVA inoculation was performed by placing the guinea pig on its 242 
back, anaesthetising with gaseous isoflurane using a Universal 243 
Vaporizer anaesthetic machine (Universal Vaporizer Support, 244 
Foster City, California, USA) and maintaining by mask with 1-245 
2% isoflurane (Pharmachem, Kearny, New Jersey, USA) and 2-6 246 
l oxygen per min. The vagina was gently opened using a sterile 247 
swab and a 3.0 mm tom-cat catheter (Henry Schein, New York, 248 
New York, USA) inserted into the cranial part of the vagina. 249 
The inoculum was then injected into the vagina, and the 250 
guinea pig maintained under anaesthesia for a further 5 min. 251 
Animal Monitoring 252 
Following inoculation, the animals were placed into individual 253 
pens and were checked twice daily (AM and PM) for any signs 254 
of systemic illness, such as increase in temperature or 255 
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respiration, vaginal opening, bleeding, or abortion. An 256 
abdominal ultrasound was conducted every day (AM) to 257 
determine number and health of foetuses, including 258 
movement and foetal heartbeat.  259 
Experimental Outcomes 260 
The primary outcome was time to abortion or time to 261 
euthanasia if no abortion had occurred by the end of the study 262 
period. Animals displaying vaginal bleeding without foetal 263 
death or expulsion of a foetus were closely monitored but 264 
were not considered to be aborting. Upon the occurrence of 265 
an abortion event (expulsion of one or more foetuses or 266 
placentas), the dam was anaesthetized, sampled and 267 
euthanized. 268 
Secondary outcomes were bacterial culture; evidence of the 269 
bacterium in tissues detected by PCR and histological evidence 270 
of infection in the reproductive tract, including metritis or 271 
placentitis. 272 
Sampling Protocol 273 
Immediately upon the detection of an abortion event or at the 274 
end of the experiment timeline had no abortions occurred, 275 
tissues were sampled for bacteria. Each guinea pig was 276 
anaesthetized with gaseous isoflurane and maintained by 277 
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mask with 1-2% isoflurane and 2-6 l oxygen per minute. The 278 
abdominal area was swabbed with iodine and rear foot 279 
reflexes and breathing monitored before commencing with 280 
the sampling process. A longitudinal cut was made in the 281 
abdominal mid-line and the peritoneal cavity was swabbed. 282 
The left uterine horn was exteriorized and sampled using a 283 
swab through a small incision into the uterus. The uterine horn 284 
was then incised and the utero-placental junctions were 285 
swabbed. The foetuses in the horn were removed with the 286 
placenta and attachment site intact (incising through the 287 
uterine wall), and placed into individual petri dishes.  288 
If the foetus had been expelled, the placenta with the 289 
attachment site was swabbed. The sampling protocol was then 290 
repeated for the right uterus horn. Due to the time sensitive 291 
nature of the procedure, plating could not be carried out at 292 
the time of sampling. To ensure the viability of the organism, 293 
all swabs were placed in an enrichment medium, Lander’s 294 
(2.1% Mueller-Hinton broth w/v (Oxoid Australia, 295 
ThermoFisher Scientific, MA, USA), 0.5% bacteriological 296 
charcoal w/v (Amyl Media, Kings Langley, Australia), 7% lysed 297 
horse blood v/v (Oxoid Australia, ThermoFisher Scientific, MA, 298 
USA), 0.4% campylobacter growth supplement v/v (Oxoid 299 
Australia, ThermoFisher Scientific, MA, USA), 0.01% 300 
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cyclohexamide w/v,0.002% vancomycin w/v, 0.001% 301 
trimethoprim w/v and 2500 IU polymyxin B w/v (Sigma 302 
Aldrich, Missouri, USA)) until delivery to the laboratory (~85 303 
km).  304 
Cardiac puncture of the dam was performed and two drops of 305 
blood were placed directly into Lander’s transport medium for 306 
culture, while the remaining volume was placed into 9 ml 307 
culture tubes for extraction of serum for PCR. Immediately 308 
following cardiac puncture the guinea pig was euthanized with 309 
2 ml of Lethabarb (Virbac, Carros, France). Amniotic fluid (AF) 310 
was collected and the foetus was incised to remove the foetal 311 
spleen and collect foetal stomach contents (FSC). AF and FSC 312 
samples were placed into individual Lander’s media. The 313 
placentas, foetuses and a 2 cm2 piece of uterus tissue were 314 
placed into individual containers of 10% NBF for histology and 315 
a 0.5 cm2 piece of the uterus horn and the spleens from the 316 
foetuses and dam were placed in individual microtubes on ice 317 
for PCR. 318 
Bacterial Culture 319 
Samples collected in Lander’s transport medium were 320 
incubated overnight at 37°C before streaking onto SBA plates 321 
and assessed at 72 h for growth of Campylobacter-like 322 
colonies. These colonies were then biochemically tested 323 
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according to international standards as published in the World 324 
Organisation for Animal Health manual (2012) to ensure the 325 
identity matched the biochemical profile of the inoculum.  326 
PCR Analysis 327 
The PCR previously described by Hum and colleagues (Hum et 328 
al., 1997) was carried out on DNA prepared from maternal and 329 
foetal spleen and dam sera from group 4-7, as well as a piece 330 
of the right uterus horn and each placenta from group 5-7. 331 
Tissue digestion and extraction was carried out using a Qiagen 332 
tissue kit (Qiagen, Hilden, Germany). Hum assay PCR primers 333 
were synthesised through Sigma (Sigma-Aldrich Pty Ltd, Castle 334 
Hill, NSW, Australia) and PCR assays were undertaken in 20 µl 335 
reaction volumes using PCR reaction buffer with 25 mM Mg2+ 336 
(10× Hotmaster™ Taq buffer, 5 Prime, Quantum Scientific, 337 
Lane Cove West, NSW, Australia), 1U Hotmaster™ Taq DNA 338 
polymerase (5 Prime, Quantum Scientific), 1 µM of each 339 
forward and reverse primers, 1 µM dNTPs (Invitrogen) and 340 
1.25 ng of C. fetus subsp. venerealis genomic DNA. 341 
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The reactions were amplified in a DNA Engine Thermal Cycler 342 
(Bio-Rad Laboratories Pty Ltd, Gladesville, NSW, Australia) 343 
using the following parameters: initial denaturation at 95°C for 344 
10 min, followed by 30 cycles of denaturation for 20 s, 345 
annealing at 50°C for 20 s, and extension at 72°C for 2 min 346 
including a final extension of 10 min at the end. Products were 347 
separated in 2% TBE (89 mM Tris borate, 2 mM EDTA, pH 8) 348 
agarose gels containing 1% GelRedTM Nucleic Acid Gel Stain 349 
(Biotium, Jomar Diagnostics P/L, Stepney, SA, Australia) using 350 
either MassRulerTM Low range DNA ladder (Fermentas, 351 
ThermoFisher Scientific, MA, USA) or HyperLadder I (Bioline, 352 
Alexandria, NSW, Australia) and were visualised under Trans-353 
UV light using the GelDocTM XR+ system (Bio-Rad Laboratories 354 
Pty Ltd, Gladesville, NSW, Australia). 355 
Histological Analysis  356 
All fixed tissue samples were trimmed through the centre-357 
most point to allow maximum area for visualisation. Placentas 358 
attached to the uterus were trimmed to allow assessment of 359 
the utero-placental junction as well as the centre of the 360 
placenta (interlobium, labyrinth and subplacenta). Foetuses 361 
were sectioned three times, through the head, thorax and 362 
abdomen. While amniotic sac samples were collected when 363 
available, due to the low number this data is omitted. The 364 
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sections were then embedded in paraffin and routinely 365 
processed for haematoxylin and eosin (H&E) staining. 366 
Histologically, neutrophil aggregation and the presence of 367 
suppurative exudate, the first indicators of infection, were 368 
used to define the level of histological infection. Neutrophils 369 
were scored on a previously used semi-quantitative scale of 0 370 
– 3 with score 0 = no neutrophils; 1 = mild neutrophil 371 
aggregation; 2 = moderate neutrophil aggregation; 3 = severe 372 
neutrophil aggregation as indicated by Figure 1 in the uterine 373 
tissue and Figure 2 in the placental tissue (Tursi et al., 2010). 374 
Statistical Analysis 375 
The time to abortion between groups was compared using 376 
Kaplan-Meier curves with the log rank test used to assess 377 
equality of survival distribution between the groups. Fisher’s 378 
exact test was used to compare the proportion of animals 379 
aborting, proportion of animals positive for C. fetus subsp. 380 
venerealis using culture or PCR and the proportion of animals 381 
with histological evidence of metritis or placentitis. Statistical 382 
analysis was performed using STATA (StataCorp LP, Texas, 383 
USA). 384 
Results 385 
Baseline Data 386 
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All animals were healthy, culture negative for Campylobacter 387 
fetus subsp. venerealis and were between 35-49 days 388 
pregnant when inoculated. Animals had a starting weight 389 
ranging from 862 g – 1020 g (mean = 973 g; standard deviation 390 
= 52 g). Vaginal swabs taken from 20 guinea pigs prior to 391 
inoculation were all negative on culture of C. fetus subsp. 392 
venerealis. 393 
Intra-peritoneal Challenge 394 
One hundred percent of the animals (excluding controls) in 395 
groups one and two (strain 258 109 CFU/ml) experienced 396 
abortion, compared to 0% in groups three (strain Q41 8.4 x 107 397 
CFU/ml), six (strain 540 1.2 x 104 CFU/ml) and seven (strain 398 
540 IVA 5.4 x 107 CFU/ml) (p = 0.03). In groups four and five 399 
(strain 540), 75% of animals experienced abortion. No control 400 
animals aborted (Table 1). 401 
Time to abortion was not statistically different between 402 
groups inoculated with the same strains at slightly different 403 
concentrations as seen in groups one and two with strain 258 404 
at 1.0 and 1.5 x 109 CFU/ml (p = 0.44) and in groups four and 405 
five with strain 540 at 1.0 x 108 CFU/ml and 3.3 x 107 CFU/ml 406 
(p = 0.62) (Figure 4). Overall, the incidence of abortion differed 407 
between at least one of the groups 1-7 (group 1 vs 3, 6 and 7 p 408 
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= 0.0067, group 2 vs 3, 6 and 7 p = 0.0058, group 5 vs 3, 6 and 409 
7 p = 0.0388, group 3 vs 4 p = 0.0401) (Figure 4). 410 
Culture isolations from peritoneum, uterus, placentas and 411 
amniotic fluid did not differ significantly between IP inoculated 412 
groups 1-5 (p = 1.00) (Figure 3). However, groups 1-5 isolations 413 
were significantly different to non-aborting groups six and 414 
seven uterus (p = 0.03) and placenta culture compared to 415 
groups one to five (respectively; p = 0.02, 0.01, <0.001, <0.001, 416 
<0.001). Amniotic fluid isolations from group 7 was 417 
significantly different compared to groups four and five (group 418 
7 vs 1 to 6 respectively p = 0.14, 1.0, 0.15, 0.007, 0.0005 and 419 
1.0). Isolations from foetal stomach fluid varied significantly 420 
between groups two and four (p = 0.003), groups two and five 421 
(p = 0.024) and between groups four and five and group 7 422 
(group 4 vs 7 p=0.002, group 5 vs 7, p=0.02). Re-isolation of the 423 
bacteria from all inoculated dams is shown in Figure 3 and 424 
numbers of placental tissue, amniotic fluid and foetal stomach 425 
content compared per group is displayed in Table 1. 426 
Biochemical and molecular profiling for each strain matched 427 
those of the inoculum. Comparative detection of the infectious 428 
organism through culture, histology or PCR showed culture to 429 
be the most consistent with re-isolation of the causative agent 430 
in every aborting dam as well as the non-aborting dams in 431 
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group 3 (Figure 3). There was no difference in culture, 432 
histology or proportion of PCR positives at an animal level per 433 
group (p = 1.00) (Figure 5). 434 
Histological evidence of infection correlated with abortion 435 
events, with non-aborting groups (group 6 and 7) showing no 436 
neutrophil aggregation (Table 1). Strain 540 at concentrations 437 
of 108 CFU/ml showed a higher level (average score = 2.4) of 438 
neutrophil cell infiltration than at 107 CFU/ml (average score = 439 
1). A high level of suppurative infiltration was seen in most 440 
abortive dam tissues, with haemorrhage and vacuolation 441 
visualized in only a few samples. 442 
Intra-vaginal Challenge 443 
None of the 4 intra-vaginally inoculated animals nor the 444 
control aborted within the 12 day (268 h) timeframe, and all 445 
animals were culture and histology negative while one sample 446 
(dam spleen) was PCR positive for C. fetus subsp. venerealis 447 
(Figure 5). 448 
Discussion 449 
This study found the pregnant guinea pig model to be a 450 
reliable and reproducible model for the study of C. fetus 451 
subsp. venerealis infection, strain virulence and dose 452 
dependency differences. The results of the study showed the 453 
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reproducibility of the model with concentrations above 107 454 
CFU/ml (strain 540 and strain 258). An increase in 455 
concentration of strain 540 by 1 log produced the same 456 
abortion rate (75%), with a decrease in the median abortion 457 
time by 20 h. Our results are consistent with a previous study 458 
where bovine strains of C. jejuni, C. fetus venerealis and C. 459 
fetus were tested at concentrations of 101, 104 and 108 CFU/ml 460 
in pregnant guinea pigs (SultanDosa et al., 1983). Inoculated 461 
dams aborted at a rate of 60% (n=9) for C. fetus (1 strain), 13% 462 
(n=4) for C. jejuni (2 strains) and 73% (n=22) for C. fetus subsp. 463 
venerealis  (2 strains) at all of the aforementioned doses 464 
within 21 days (SultanDosa et al., 1983). Abortions or abortive 465 
symptoms predominantly occurred within 2-17 days post-466 
inoculation with an average of 7 days. The study also noted 467 
dose dependency, with the highest rate and shortest time to 468 
abortion produced at the highest dose amongst all strains 469 
used (SultanDosa et al., 1983). 470 
In the present study, although none of the strain Q41 471 
(ATCC19438) inoculated animals aborted, the bacterium was 472 
reisolated in all dams from a combination of 4 of the 7 culture 473 
sites (Figure 3; Table 1). This strain appeared to be less virulent 474 
than the previous strain (258) within the timeframe (7 days) 475 
resulting in an increase in the study endpoint to 12 days to 476 
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account for less virulent strains. Previous studies have used 2 477 
days (Burrough et al., 2011), 12 days (Coid et al., 1987) and 21 478 
days (Burrough et al., 2009) for C. jejuni and C. coli. However C. 479 
fetus subsp. venerealis, has been shown in cattle to require 480 
longer incubation times as seen in aborting heifers which are 481 
often affected in the third trimester of pregnancy (Hum, 482 
2009). This was also seen in the initial C. fetus subsp. 483 
venerealis guinea pig study  with up to 34 days required as the 484 
study endpoint (Ristic and Morse, 1953). The shortest effective 485 
time-point was used in this study to avoid euthanizing fully 486 
developed foetuses in non-aborting dams. 487 
In cattle, inflammation in the uterus is associated with 488 
infection as an indicator of campylobacteriosis associated 489 
endometritis (Clark, 1971). Placentitis has been described as 490 
an infection mechanism of C. fetus subsp. fetus in ewes 491 
following bacteraemia, as well as in humans, as a mechanism 492 
of abortion due to orally transmitted C. jejuni and C. coli 493 
(Skirrow, 1994). Burrough et al (2011a) using a C. jejuni guinea 494 
pig model, showed that the organism had a high tropism for 495 
the placenta, suggesting the presence of a ‘chemoattractive 496 
placental factor’ which may account for the high level of 497 
placental isolations seen in their study.  498 
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In cattle the bacteria are transmitted venereally, however, 499 
studies have shown that fertilization itself is not affected by C. 500 
fetus subsp. venerealis but rather fertility decreased by a 501 
reduction in implantation (Bielanski et al., 1994; Skirrow, 1994; 502 
Wilkie and Winter, 1971). These studies suggest that infection 503 
of the guinea pigs at the time of fertilization was not necessary 504 
to produce a comparative model for bovine infection. We 505 
found that inoculation by the IVA route was ineffective in 506 
producing infection or abortion. It is possible that organisms 507 
failed penetrate the cervix at the time of inoculation. 508 
A more recent study into a virulence factor associated with C. 509 
jejuni infection, luxS, showed that it had the capability to 510 
affect motility, colonization and toxin production, and was 511 
directly linked to the bacteria’s ability to produce abortion in 512 
guinea pig and chicken models (Plummer, 2012). While the 513 
luxS gene is present in C. fetus subsp. venerealis (Stynen et al., 514 
2011) its involvement in bacterial pathogenicity is unknown. A 515 
disruption of virD4 (an essential component of the bacterial 516 
Type IV secretion apparatus) in C. fetus subsp. venerealis 517 
showed a 50% reduction in cell invasion in vitro compared to 518 
the original wild type strain (Gorkiewicz et al., 2010). Such 519 
studies to date have been undertaken using in vitro culture 520 
invasion assays but could also incorporate the use of gene 521 
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specific mutants to assist in the screening of potential 522 
virulence factors (Gorkiewicz et al., 2010; Kienesberger et al., 523 
2007).  524 
While the effect on fertilization could not be tested in this 525 
study as it was not possible to infect the guinea pigs at the 526 
time of mating, due to the similar end-point of this infection 527 
model and bovine pathogenesis – inflammation in the uterus 528 
and placenta causing early embryonic death and late 529 
abortions, this model is valid for use in studying bovine strain 530 
variations and infection mechanisms.  531 
Culture has been, and still remains the gold standard for the 532 
diagnosis of BGC in infected cattle (World Organisation for 533 
Animal Health, 2012). Culture was reliable and consistent with 534 
high levels of re-isolation of bacteria from different sites in the 535 
animals. However, culture sensitivity at an animal level was 536 
lower than that of PCR in this study, with one sample in a dam 537 
inoculated via the IVA route positive by PCR but negative by 538 
culture or histology. This could be due to the infection 539 
becoming systemic and clearing through the spleen leaving 540 
residual DNA. However, due to the low number of samples 541 
tested by PCR in this study, further investigation and validation 542 
would be necessary before its recommended use in further 543 
studies. 544 
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This study has shown the difference between the ability of C. 545 
fetus subsp. venerealis strains to cause abortions at similar 546 
concentrations with strain Q41 (ATCC19438) having no effect 547 
while strains 258 and 540 had abortion rates of 100% and 75% 548 
respectively. Two studies using different strains (C. fetus and C. 549 
jejuni) at a concentration of 105 CFU/ml found that IP injection 550 
of pregnant guinea pigs produced 83% abortions with 21 days 551 
with C. jejuni and 100% abortions within 12 days with C. fetus 552 
(Burrough et al., 2009; Coid et al., 1987). However, in the 553 
current experiment the C. fetus subsp. venerealis strain 540 at 554 
1.2 x 104 CFU/ml did not result in any abortions or show 555 
evidence of progression of infection. Genomic profiling may 556 
identify differences which may explain these results and also 557 
provide insights into genes which may be associated with 558 
higher virulence. The C. fetus subsp. venerealis strains used in 559 
this study appear to require a higher infective dose to produce 560 
abortions when compared to both C. fetus and C. jejuni 561 
(Burrough et al., 2009; Coid et al., 1987). The differences 562 
between previous studies and the present study include 563 
animal model species, infective dose, time to abortion, 564 
geographical origin of the strains and strain pathogenicity.  565 
A limitation is that only three different strains were tested, 566 
strain Q41 (ATCC19438) only once, as well as the limited doses 567 
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tested. In contrast with other studies which used vaginal 568 
bleeding as the study endpoint, this study used abortion 569 
(defined as expulsion of one or more foetuses and/or 570 
placentas) as the endpoint (Burrough et al., 2011; Plummer, 571 
2012). An important limitation on the interpretation of results 572 
occurred when samples were not readily collectable. In the 573 
instance of abortions, the dam would occasionally eat the 574 
placenta and/or part of the foetus and the amniotic sac 575 
become damaged and desiccated. With the occurrence of 576 
acute abortions, the presence of very small foetuses resulted 577 
in insignificant foetal stomach fluids and foetal spleen 578 
available for testing. 579 
This study defined parameters for a route of infection, dose 580 
and study end-point to ensure the validity and reproducibility 581 
of a C. fetus subsp. venerealis infection model. It has also 582 
identified the most consistent sites for isolation of C. fetus 583 
subsp. venerealis and the most accurate method for 584 
evaluation of infection. The study has shown that the pregnant 585 
guinea pig model described here is promising for the 586 
assessment of further C. fetus subsp. venerealis strains. 587 
Defining the pathogenic and genomic variation of C. fetus 588 
subsp. venerealis strains may help ascertain the involvement 589 
of different bacterial virulence factors in BGC. This is a 590 
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valuable model for the testing of different strains to improve 591 
the understanding of bovine genital campylobacteriosis. 592 
Acknowledgments 593 
Many thanks to the technical staff at DAFF (Lucia Mascali, 594 
Howard Prior, and Catherine Minchin) for their laboratory 595 
assistance as well as Nicole Broad (UQ Vet School) for animal 596 
husbandry. We are grateful to Léa Indjein for the collection of 597 
isolates used in this study. 598 
Funding Source 599 
This study was funded by the Australian Research Council 600 
(LP0883837). 601 
602 
Page 28 of 36
 Page 29 
29 
References: 603 
Bielanski, A., Sampath, M., Gradil, C., Eaglesome, M.D., Garcia, M., 604 
1994. In vitro Fertilization of Bovine Ova in the Presence of 605 
Campylobacter fetus subsp. venerealis. Reproduction in 606 
Domestic Animals 29, 488-493. 607 
Burrough, E.R., 2011. Investigation of an emergent, tetracycline-608 
resistant, abortifacient Campylobacter jejuni clone in a 609 
pregnant guinea pig model. Ph.D. Veterinary Pathology, 610 
United States -- Iowa. 611 
Burrough, E.R., Sahin, O., Plummer, P.J., DiVerde, K.D., Zhang, Q., 612 
Yaeger, M.J., 2011. Comparison of two commercial ovine 613 
Campylobacter vaccines and an experimental bacterin in 614 
guinea pigs inoculated with Campylobacter jejuni. American 615 
Journal of Veterinary Research 72, 799-805. 616 
Burrough, E.R., Sahin, O., Plummer, P.J., Zhang, Q., Yaeger, M.J., 617 
2009. Pathogenicity of an emergent, ovine abortifacient 618 
Campylobacter jejuni clone orally inoculated into pregnant 619 
guinea pigs. American Journal of Veterinary Research 70, 620 
1269-1276. 621 
Clark, B.L., 1971. Review of Bovine Vibriosis. Australian Veterinary 622 
Journal 47, 103-107. 623 
Clark, B.L., Dufty, J.H., Monsbourgh, J., Parsonson, I.M., 1975. 624 
Studies on Venereal Transmission of Campylobacter Fetus 625 
by Immunised Bulls. Australian Veterinary Journal 51, 531-626 
532. 627 
Cobo, E.R., Cipolla, A., Morsella, C., Cano, D., Campero, C., 2003. 628 
Effect of Two Commercial Vaccines to Campylobacter fetus 629 
subspecies on Heifers Naturally Challenged. Journal of 630 
Veterinary Medicine, Series B 50, 75-80. 631 
Coid, C.R., O'Sullivan, A.M., Dore, C.J., 1987. Variations in the 632 
virulence, for pregnant guinea pigs, of campylobacters 633 
isolated from man. Journal of Medical Microbiology 23, 187-634 
189. 635 
Gorkiewicz, G., Kienesberger, S., Schober, C., Scheicher, S.R., Gully, 636 
C., Zechner, R., Zechner, E.L., 2010. A Genomic Island 637 
Defines Subspecies-Specific Virulence Features of the Host-638 
Adapted Pathogen Campylobacter fetus subsp. venerealis. 639 
Journal of Bacteriology 192, 502-517. 640 
Gorman, R., Adley, C.C., 2004. An evaluation of five preservation 641 
techniques and conventional freezinf temperatures of -20C 642 
and -85`C for long-term preservation of Campylobacter 643 
jejuni. Letters in Applies Microbiology 38, 306-310. 644 
Hum, S., Hornitzky, M., Berg, T. 2009. Bovine Genital 645 
Campylobacteriosis. In Australia and New Zealand Standard 646 
Diagnostic Procedures, SCAHLS, ed. (Department of 647 
Agriculture, Fisheries and Forrestry). 648 
Hum, S., Quinn, K., Brunner, J., On, S.L.W., 1997. Evaluation of a PCR 649 
assay for identification and differentiation of Campylobacter 650 
fetus subspecies. Australian Veterinary Journal 75, 827-831. 651 
Page 29 of 36
 Page 30 
30 
Indjein, L., 2013. Molecular profile of Campylobacter fetus subsp. 652 
venerealis. The University of Queensland, Brisbane, 653 
Australia. 654 
Kienesberger, S., Gorkiewicz, G., Joainig, M.M., Scheicher, S.R., 655 
Leitner, E., Zechner, E.L., 2007. Development of 656 
experimental genetic tools for Campylobacter fetus. Appl 657 
Environ Microbiol 73, 4619-4630. 658 
Meynell, G.G., Meynell, E., 1970. Theory and practice in 659 
experimental bacteriology, 2d Edition. University Press, 660 
Cambridge, Eng., xiv, 346 p. pp. 661 
Plummer, P., Sahin, O., Burrough, E., Sippy, R., Mou, K., Rabenold, J., 662 
Yaeger, M., Zhang, Q., 2012. Critical Role of LuxS in the 663 
Virulence of Campylobacter jejuni in a Guinea Pig Model of 664 
Abortion. Infection and Immunity 80, 585-593. 665 
Ristic, M., Morse, E.V., 1953. Experimental Vibrio fetus infection in 666 
Guinea pigs. I. Bacteriological aspects. American Journal of 667 
Veterinary Research 14, 399-404. 668 
Skirrow, M.B., 1994. Diseases due to Campylobacter, Helicobacter 669 
and related bacteria. Journal of Comparative Pathology 111, 670 
113-149. 671 
Stockard, C.R., Papanicolaou, G.N., 1919. The vaginal closure 672 
membrane, copulation, and the vaginal plug in the guinea-673 
pig, with further considerations of the oestrus rhythm. The 674 
Biological Bulletin 37, 222-245. 675 
Stynen, A.P., Lage, A.P., Moore, R.J., Rezende, A.M., de Resende, 676 
V.D., Ruy Pde, C., Daher, N., Resende Dde, M., de Almeida, 677 
S.S., Soares Sde, C., de Abreu, V.A., Rocha, A.A., dos Santos, 678 
A.R., Barbosa, E.G., Costa, D.F., Dorella, F.A., Miyoshi, A., de 679 
Lima, A.R., Campos, F.D., de Sa, P.G., Lopes, T.S., Rodrigues, 680 
R.M., Carneiro, A.R., Leao, T., Cerdeira, L.T., Ramos, R.T., 681 
Silva, A., Azevedo, V., Ruiz, J.C., 2011. Complete genome 682 
sequence of type strain Campylobacter fetus subsp. 683 
venerealis NCTC 10354T. J Bacteriol 193, 5871-5872. 684 
SultanDosa, A.B., Bryner, J.H., Foley, J.W., 1983. Pathogenicity of 685 
Campylobacter jejuni and Campylobacter coli strains in the 686 
pregnant guinea pig model. American Journal of Veterinary 687 
Research 44, 2175-2178. 688 
Taylor, D.E., Bryner, J.H., 1984. Plasmid content and pathogenicity of 689 
Campylobacter jejuni and Campylobacter coli strains in the 690 
pregnant guinea pig model. American Journal of Veterinary 691 
Research 45, 2201-2202. 692 
Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Aiello, F., 2010. 693 
Predictive value of serologic markers of degree of histologic 694 
damage in acute uncomplicated colonic diverticulitis. 695 
Journal of clinical gastroenterology 44, 702-706. 696 
Wilkie, B., Winter, A., 1971. Bovine vibriosis: the distribution and 697 
specificity of antibodies induced by vaccination and 698 
infection and the immunofluorescent localization of the 699 
organism in infected heifers. Canadian Journal of 700 
Comparative Medicine 35, 301. 701 
Page 30 of 36
 Page 31 
31 
Willoughby, K., Nettleton, P.F., Quirie, M., Maley, M.A., Foster, G., 702 
Toszeghy, M., Newell, D.G., 2005. A multiplex polymerase 703 
chain reaction to detect and differentiate Campylobacter 704 
fetus subspecies fetus and Campylobacter fetus -species 705 
venerealis: use on UK isolates of C. fetus and other 706 
Campylobacter spp. Journal of Applied Microbiology 99, 707 
758-766. 708 
World Organisation for Animal Health, 2012. Manual of Diagnostic 709 
Tests and Vaccines for Terrestrial Animals, Vol 1. World 710 
Organisation for Animal Health. 711 
 712 
LIST OF TABLES 713 
Table 1. Summary of concentrations of three Campylobacter 714 
fetus subsp. venerealis strains used for inoculation of groups 1-715 
7 of 4 guinea pigs and control group of 7 guinea pigs (one per 716 
group) each via either intra-peritoneal (IP) or intra-vaginal 717 
(IVA) route as well as time to study end-point, interquartile 718 
range of time to and percentage of abortions. Number of 719 
samples from IP inoculated dams (n=4 per group) which were 720 
culture positive for Campylobacter fetus subsp. venerealis in 721 
all foetuses (aborted and non-aborted) from groups 1-6. In the 722 
instance of abortions there was subsequent loss of samples 723 
due to fluid drying or dam eating all or part of placenta and 724 
foetus. Neutrophil aggregation scores for groups 1-7 as seen in 725 
uterus and placental tissues of inoculated dams. Foetal tissue 726 
samples (head, thorax, abdomen) showed no neutrophil 727 
infiltration suggestive of inflammatory response. Insufficient 728 
samples for an accurate representation of amniotic sac 729 
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infection were collected due to loss during abortion and/or 730 
desiccation and are therefore not shown. 731 
 732 
LEGEND TO FIGURES 733 
Figure 1. Uterine photomicrographs from Campylobacter fetus 734 
subsp. venerealis inoculated guinea pigs showing the 735 
inflammatory scale used for grading of neutrophil cellular 736 
infiltration. H&E stain; bar = 200µm. A – scale 0; normal 737 
endometrium (EM) and myometrium (MM). B – scale 1; 738 
scattered neutrophils within the EM. C – scale 2; neutrophils 739 
within the submucosa (SM) and EM and neutrophil exudate 740 
(NE). D – scale 3; widespread accumulation of NE along the EM 741 
and scattered within the MM. E - Non-infected control dam 742 
from group 1 showing EM tissue with no signs of inflammatory 743 
response (scale 0) X400. F – Infected dam from group 1 744 
showing hyper-cellularity with evidence of inflammatory 745 
response, most notably infiltration of neutrophils and 746 
congestion of tissue (scale 3) X400. 747 
Figure 2. Placental photomicrographs from Campylobacter 748 
fetus subsp. venerealis inoculated guinea pigs showing the 749 
inflammatory scale used for grading of neutrophil infiltration. 750 
H&E stain; bar = 200µm. A – scale 0;  normal placental tissue 751 
Page 32 of 36
 Page 33 
33 
within the junctional zone (JZ), subplacenta (SP) and chorio-752 
allontoic placenta (CAP). B – scale 1; scattered neutrophils 753 
within the JZ. C – scale 2; neutrophils within the SP and areas 754 
of neutrophil exudate (NE). D - scale 3; widespread 755 
accumulation of NE along and scattered within the SP. E - Non-756 
infected control dam from group 4 showing normal yolk sac 757 
placenta with no signs of inflammatory response (scale 0) 758 
X400.  F - Infected dam from group 4 yolk sac placenta 759 
showing congestion of blood vessels, necrosis of epithelial 760 
cells and moderate inflammatory cell infiltrate comprising 761 
neutrophils and lymphocytes (scale 3) X400. 762 
Figure 3. Percentage of samples from each of the three 763 
anatomical sites of inoculated dams which were culture 764 
positive for Campylobacter fetus subsp. venerealis in aborting 765 
and non-aborting instances (n=4) in groups 1-7 (see Table 1). 766 
No blood samples were collected in groups 1-3. 767 
Figure 4. Kaplan-Meier survival estimates of groups 1-7 768 
showing abortion incidences to end-point with log rank for 769 
equality of survivor function chi2 = 24.16 and Pr>Chi2 = 0.0005. 770 
Figure 5. Comparison of bacterial presence detected through 771 
culture, histology and PCR in inoculated animals (n=4) of 772 
groups 1-7 (see Table 1). The criterion for a positive result was 773 
a minimum of one positive sample per animal for each test. 774 
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Culture results are from isolations in peritoneum, uterus, 775 
placenta, blood, amniotic fluid or foetal stomach contents. 776 
Histological findings were associated with metritis or 777 
placentitis per animal and positive PCR results for uterus, 778 
spleen, serum or placenta for each inoculated animal. PCR was 779 
not done on samples in groups 1-4. 780 
 781 
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*h – hours; IQR – interquartile range; N/A – not applicable; CFU/ml – colony forming units per millilitre; AF – amniotic fluid; FSC – foetal stomach contents; n - number 
^control group consisted of 1 animal per group 1-7 inoculated with sterile broth via the same route and endpoint. 
A
 – time to abortion significantly different to group 3, 6 
and 7 (p=0.0067); 
B
 – time to abortion significantly different to groups 3, 6 and 7 (p=0.0058); 
C
 – time to abortion significantly different to groups 3, 6 and 7 (p=0.0401); 
D
 – 
time to abortion significantly different to groups 3, 6 and 7 (p=0.0388). 
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